Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05068583 · ClinicalTrials.gov registry record
Liquid Biopsies in Pediatric Solid Tumors
A clinical trial of Pediatric Solid Tumor, Unspecified, Protocol Specific, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT05068583: Recruiting study of Pediatric Solid Tumor, Unspecified, Protocol Specific, sponsored by Children's Hospital Los Angeles.
NCT05068583 is a study of Pediatric Solid Tumor, Unspecified, Protocol Specific that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 320 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05068583, a study of Pediatric Solid Tumor, Unspecified, Protocol Specific, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine if traces of tumor can be found in the blood before, during, and after patients stop treatment. We will analyze the tumor material to see if it is similar to tumor tissue and if the tumor material in blood is helpful in monitoring the disease.
Primary Outcome
To determine how often circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and circulating tumor RNA (ctRNA) is detected in serial blood samples from patients with newly diagnosed and relapsed/refractory malignant pediatric solid tumors.
Conditions Studied
Interventions
- OTHER Blood Draw
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2019-05-08 |
| Est. Completion | 2034-05-08 |
What NCT05068583 shows while recruiting
NCT05068583 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pediatric Solid Tumor, Unspecified, Protocol Specific appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.
NCT05068583 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05068583 about?
NCT05068583 is a clinical study titled "Liquid Biopsies in Pediatric Solid Tumors". This study is being done to determine if traces of tumor can be found in the blood before, during, and after patients stop treatment. We will analyze the tumor material to see if it is similar to tumor tissue and if the tumor material in blood is helpful in monitoring the disease.
What is the current status of trial NCT05068583?
This trial is currently recruiting. The enrollment target is 320 participants. The study started on 2019-05-08. Estimated completion is 2034-05-08.
What conditions does trial NCT05068583 study?
This clinical trial studies the following conditions: Pediatric Solid Tumor, Unspecified, Protocol Specific.
What interventions are being tested in trial NCT05068583?
The interventions under investigation include: Blood Draw (OTHER).
Who is sponsoring clinical trial NCT05068583?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05068583 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI